Polymorphic variation in the CBLB gene in human type 1 diabetes.

Area of Science:

• Immunogenetics
• Molecular Biology
• Endocrinology

Background:

• The CBLB gene plays a role in T-cell costimulatory signaling and is linked to autoimmunity.
• Cblb is a significant diabetes-predisposing locus in the Komeda diabetes-prone (KDP) rat model.
• Cbl-b, a ubiquitin ligase, regulates T-cell activation by coupling T-cell receptor (TCR) and CD28 costimulation.

Purpose of the Study:

• To evaluate CBLB as a candidate gene for type 1 diabetes (T1D) susceptibility in humans.
• To identify functional variants and haplotype-tagging polymorphisms within the human CBLB gene.
• To assess the association between CBLB gene variants and T1D risk.

Main Methods:

• Sequencing of the human CBLB coding region in 16 individuals with T1D.
• Genotyping of seven single-nucleotide polymorphism (SNP) markers across the CBLB gene.
• Transmission disequilibrium testing (TDT) in multiplex T1D families to assess genetic association.

Main Results:

• No variants predicted to alter the amino acid sequence of CBLB were found in T1D patients.
• No significant association was detected between individual CBLB SNP markers and T1D.
• No significant association was found for CBLB marker haplotypes with T1D susceptibility.

Conclusions:

• The human CBLB gene does not appear to be a major susceptibility gene for type 1 diabetes.
• Sequence analysis did not reveal functional variants in the coding region of CBLB associated with T1D.
• Genetic association studies using SNPs and haplotypes did not support CBLB's role in T1D pathogenesis.